View More Recent Stories
-
Insmed (INSM) PT Raised to $98 at TD Cowen
-
Insmed (INSM) Misses Q2 EPS by 70c ; Offers Guidance
-
RBC's biotech survey shows investors more bearish vs. last time
-
2Q24 U.S. biotech earnings preview
-
Mizuho Reiterates Outperform Rating on Insmed (INSM)
-
TD Cowen Reiterates Buy Rating on Insmed (INSM)
-
H.C. Wainwright Reiterates Buy Rating on Insmed (INSM)
-
Insmed (INSM) PT Raised to $88 at Truist Securities
-
Insmed (INSM) Redeems $225M of Notes
-
Insmed (INSM) PT Raised to $90 at Barclays
-
Insmed (INSM) PT Raised to $75 at Evercore ISI
-
These stocks are Wells Fargo's 14 high-conviction ideas for Q2

